| MAP | Methotrexate, doxorubicin, and cisplatin combination treatment |
| AP | Doxorubicin and cisplatin combination treatment |
| MTX | Methotrexate |
| DOX | Doxorubicin |
| CDDP | Cisplatin |
| TARGET | Therapeutically Applicable Research to Generate Effective Treatments |
| ODE | Ordinary differential equation |
| HMGB1 | High mobility group box 1 |
| DAMP | Damage-associated molecular pattern |
| NK | Natural killer |